Literature DB >> 1814905

Cardiac changes implicated in chronic heart block.

M Panja1, A L Dutta, A K Kar, S Panja, M K Chhetri.   

Abstract

Fifteen cases of chronic heart block were studied. Eight of them could be designated as idiopathic or primary heart block; the others were associated with hypertension, diabetes and ischaemic heart disease, either singly or in various combinations. In six cases, the whole heart was available for histopathological study of the conduction system. In the other 9 cases, only a portion of the heart muscle was available for examination. A V nodal fibrosis extending upto the proximal bundle of His was seen in all the six whole heart autopsy materials. Fibrosis of the adjacent myocardium was seen in five cases. In three cases, conducting system fibrosis was associated with atherosclerotic (1 case) or diabetic changes (3 cases) of the intramural vessels. In the 9 partial autopsy studies, myocardial fibrosis was seen in two cases, diabetic microangiopathy in one and atherosclerotic changes in two including an old thrombus in one. Thus, diabetic microangiopathy was seen in total four cases. These changes may be responsible for the cardiomegaly and cardiac failure associated with conduction defects observed in diabetes. In the idiopathic group also, heart block could be considered as a significant facet of a primary myocardial degenerative process.

Entities:  

Mesh:

Year:  1991        PMID: 1814905

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  2 in total

1.  Prevalence of diabetes in elderly patients requiring permanent cardiac pacemaker insertion.

Authors:  J T Lear; I G Lawrence; A C Burden
Journal:  Acta Diabetol       Date:  1996-07       Impact factor: 4.280

2.  Remote ischemic preconditioning differentially attenuates post-ischemic cardiac arrhythmia in streptozotocin-induced diabetic versus nondiabetic rats.

Authors:  Zhaoyang Hu; Mou Chen; Ping Zhang; Jin Liu; Geoffrey W Abbott
Journal:  Cardiovasc Diabetol       Date:  2017-04-26       Impact factor: 9.951

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.